Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1

Sponsor
National Institute on Drug Abuse (NIDA) (NIH)
Overall Status
Unknown status
CT.gov ID
NCT00519259
Collaborator
(none)
12
1

Study Details

Study Description

Brief Summary

The purpose of this study is to assess safety and pharmacokinetics of sublingual lobeline in healthy normal volunteers.

Condition or Disease Intervention/Treatment Phase
Phase 1

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Tolerability, Safety, and Pharmacokinetics of Repeated Sublingual Doses of Lobeline
Study Start Date :
Feb 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Tolerability []

Secondary Outcome Measures

  1. Safety []

  2. Pharmacokinetic parameters []

  3. Cardiovascular responses []

  4. Psychological effects of lobeline []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Must be able to provide written informed consent

  • Must have a body mass index between 18 and 30

  • Have no medical contraindications as determined by medical history, physical exam, ECG, hematology and blood chemistry profile, and urinalysis

  • Must have a negative drug test at screening and admission

  • If female of child bearing potential, must agree to use birth control

Exclusion Criteria:
  • Please contact the site for more information

Contacts and Locations

Locations

Site City State Country Postal Code
1 Langley Porter Psychiatric Institute San Francisco California United States 94143

Sponsors and Collaborators

  • National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Reese Jones, M.D., Langley Porter Psychiatric Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00519259
Other Study ID Numbers:
  • NIDA-CPU-0009-1
First Posted:
Aug 22, 2007
Last Update Posted:
Jan 11, 2017
Last Verified:
Jun 1, 2006
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2017